Consumer Edge Launches Research Signal Healthcare to Help Investors Forecast Earnings

New Analyst-Built Reports Pair Revenue Forecasts with Insights Derived from Hospital Purchase, Medical Claims and Pharmacy Claims Data

Each Quarter Provides an Intraquarter Trends Read and a Quarter-End Earnings Preview, with Estimates Positioned Against Consensus and Backtested Against Reported Results

NEW YORK, Oct. 27, 2026 /PRNewswire/ -- Consumer Edge, the leading provider of global consumer data-driven insights, launched Research Signal Healthcare, the healthcare arm of Consumer Edge's Research Signal offering. It is the first healthcare research product to draw on hospital purchase data, medical claims and pharmacy claims, giving investors recurring, analyst-built reports with revenue forecasts and competitive context timed to the earnings cycle.

"Healthcare investors have had to choose between claims data that shows utilization and purchase data that shows actual demand at the point of purchase. Research Signal Healthcare brings both together in one report," said Bill Pecoriello, CEO, Consumer Edge. "It pairs a verifiable forecast with the competitive and category context behind it, reconciled against management's own commentary. Whether a firm is cross-validating a med-tech trend or tracking specialty drug sales, Research Signal Healthcare delivers a more complete, data-driven view ahead of earnings."

Key capabilities of Research Signal Healthcare include:

• Multi-dataset construction: Reports draw from Consumer Edge's proprietary hospital purchase data, medical claims, and pharmacy claims, alone or in combination. Combining datasets allows med-tech trends to be cross-validated from both the purchasing and utilization sides, giving investors greater conviction built on a more complete data foundation.
• Two reads per quarter, timed ahead of the market: An intra-quarter trends report flags whether a name is accelerating or decelerating and why. The quarter-end earnings report delivers a Consumer Edge revenue forecast, shown against consensus, and reconciles management commentary against the data ahead of the print.
• Verifiable analyst forecasts: Each quarter-end earnings report includes a backtest of Consumer Edge estimates against reported results, built by Consumer Edge's healthcare analysts, so clients can evaluate the track record themselves.
• Tailored analysis across four entity levels: Each report is scoped to product, franchise, ticker or market, with detailed breakdowns of drivers including competitive share, payer mix, site of care, indication mix, and persistence. This context helps clients understand what is driving a trend and what to watch ahead of earnings.
• One unified report, not multiple fragmented sources: Forecasts, trend drivers, competitive dynamics, category-scoped cuts and a risks and considerations section are delivered in a single report, with no need to assemble data across providers or translate raw data into a usable view. A companion Excel file carries every underlying number.

Research Signal Healthcare launches with 10 reports spanning the pharmaceutical, biotechnology and medical technology sectors.. To learn more or schedule a demo, click here.

About Consumer Edge
Consumer Edge ("CE") is a leading data and insights-as-a-service (IaaS) company specializing in the global consumer, B2B, and healthcare economies. Founded in 2009 by CEO Bill Pecoriello, CE delivers real-time, transaction-based intelligence enriched by deep industry expertise. Its solutions equip corporate and investment leaders with best-in-class tools for strategic decision-making, offering granular insights and benchmarking across products, brands, sub-industries, and industries. CE's unique capabilities turn complex data into clear, actionable insights that drive smarter, faster decisions.

Media Contacts
Raquel Cona / Michaela Fawcett
KCSA Strategic Communications
[email protected] / [email protected]

SOURCE Consumer Edge